Targeted therapy for immune mediated skin diseases. What should a dermatologist know?

• Κύριοι συγγραφείς: Edinson López (Συγγραφέας), Raúl Cabrera (Συγγραφέας), Cristóbal Lecaros (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Sociedade Brasileira de Dermatologia, 2024-07-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Abstract Background Molecularly targeted therapies, such as monoclonal antibodies (mAbs) and Janus Kinase inhibitors (JAKis), have emerged as essential tools in the treatment of dermatological diseases. These therapies modulate the immune system through specific signaling pathways, providing effecti...